New Results
GLP-1R agonist NLY01 reduces retinal inflammation, astrocyte reactivity, and retinal ganglion cell death secondary to ocular hypertension
View ORCID ProfileJacob K. Sterling, Modupe Adetunji, Samyuktha Guttha, Albert Bargoud, Katherine Uyhazi, Ahmara G. Ross, Joshua L. Dunaief, Qi N. Cui
doi: https://doi.org/10.1101/2020.06.18.146720
Jacob K. Sterling
1FM Kirby Center for Molecular Ophthalmology, Scheie Eye Institute, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA
2Medical Scientist Training Program, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA
Modupe Adetunji
1FM Kirby Center for Molecular Ophthalmology, Scheie Eye Institute, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA
Samyuktha Guttha
1FM Kirby Center for Molecular Ophthalmology, Scheie Eye Institute, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA
3Grossman School of Medicine, New York University, New York, NY 10016, USA
Albert Bargoud
1FM Kirby Center for Molecular Ophthalmology, Scheie Eye Institute, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA
4Rutgers New Jersey Medical School, Newark, NJ 07103, USA
Katherine Uyhazi
1FM Kirby Center for Molecular Ophthalmology, Scheie Eye Institute, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA
Ahmara G. Ross
1FM Kirby Center for Molecular Ophthalmology, Scheie Eye Institute, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA
Joshua L. Dunaief
1FM Kirby Center for Molecular Ophthalmology, Scheie Eye Institute, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA
Qi N. Cui
1FM Kirby Center for Molecular Ophthalmology, Scheie Eye Institute, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA
Article usage
Posted June 19, 2020.
GLP-1R agonist NLY01 reduces retinal inflammation, astrocyte reactivity, and retinal ganglion cell death secondary to ocular hypertension
Jacob K. Sterling, Modupe Adetunji, Samyuktha Guttha, Albert Bargoud, Katherine Uyhazi, Ahmara G. Ross, Joshua L. Dunaief, Qi N. Cui
bioRxiv 2020.06.18.146720; doi: https://doi.org/10.1101/2020.06.18.146720
GLP-1R agonist NLY01 reduces retinal inflammation, astrocyte reactivity, and retinal ganglion cell death secondary to ocular hypertension
Jacob K. Sterling, Modupe Adetunji, Samyuktha Guttha, Albert Bargoud, Katherine Uyhazi, Ahmara G. Ross, Joshua L. Dunaief, Qi N. Cui
bioRxiv 2020.06.18.146720; doi: https://doi.org/10.1101/2020.06.18.146720
Subject Area
Subject Areas
- Biochemistry (11697)
- Bioengineering (8714)
- Bioinformatics (29116)
- Biophysics (14924)
- Cancer Biology (12047)
- Cell Biology (17347)
- Clinical Trials (138)
- Developmental Biology (9405)
- Ecology (14136)
- Epidemiology (2067)
- Evolutionary Biology (18260)
- Genetics (12214)
- Genomics (16758)
- Immunology (11838)
- Microbiology (27986)
- Molecular Biology (11544)
- Neuroscience (60776)
- Paleontology (450)
- Pathology (1864)
- Pharmacology and Toxicology (3228)
- Physiology (4936)
- Plant Biology (10381)
- Synthetic Biology (2876)
- Systems Biology (7331)
- Zoology (1642)